Compare FNLC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNLC | RLMD |
|---|---|---|
| Founded | 1864 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.9M | 461.9M |
| IPO Year | 1995 | 2012 |
| Metric | FNLC | RLMD |
|---|---|---|
| Price | $36.64 | $3.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 33.4K | ★ 1.4M |
| Earning Date | 10-21-2026 | 11-12-2026 |
| Dividend Yield | ★ 4.20% | N/A |
| EPS Growth | 26.34 | ★ 45.28 |
| EPS | ★ 1.65 | N/A |
| Revenue | N/A | ★ $13,070.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.84 | ★ N/A |
| Revenue Growth | N/A | ★ 154.83 |
| 52 Week Low | $24.39 | $2.15 |
| 52 Week High | $36.30 | $8.00 |
| Indicator | FNLC | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.93 | 39.10 |
| Support Level | $34.28 | $3.13 |
| Resistance Level | N/A | $3.55 |
| Average True Range (ATR) | 0.94 | 0.21 |
| MACD | 0.35 | 0.03 |
| Stochastic Oscillator | 100.00 | 39.57 |
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.